Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)

Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)

Show other versions (1)

A western lifestyle, characterised by low rates of energy expenditure and a high-energy diet rich in animal protein, saturated fats and refined carbohydrates, is associated with high incidence of prostate cancer in men. A high-energy nutritional status results in insulin/IGF signalling in cells, whi...

Full description

Bibliographic Details
Main Authors:	Campa, D, Hüsing, A, Chang-Claude, J, Dostal, L, Boeing, H, Kröger, J, Tjønneland, A, Roswall, N, Overvad, K, Dahm, C, Rodríguez, L, Sala, N, Pérez, M, Larrañaga, N, Chirlaque, M, Ardanaz, E, Khaw, K, Wareham, N, Allen, N, Travis, R, Trichopoulou, A, Naska, A, Bamia, C, Palli, D, Sieri, S
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).
by: Campa, D, et al.
Published: (2011)

Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on Cancer.
by: Campa, D, et al.
Published: (2011)

Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)
by: Campa, D, et al.
Published: (2011)

Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC).
by: Campa, D, et al.
Published: (2011)

Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC)
by: Campa, D, et al.
Published: (2010)

Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC
by: Travis, R, et al.
Published: (2012)

Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC.
by: Travis, R, et al.
Published: (2012)

Vasectomy and prostate cancer risk in the European Prospective Investigation Into Cancer and Nutrition (EPIC)
by: Smith Byrne, K, et al.
Published: (2017)

Plasma cotinine levels and pancreatic cancer in the EPIC cohort study
by: Leenders, M, et al.
Published: (2011)

Plasma cotinine levels and pancreatic cancer in the EPIC cohort study.
by: Leenders, M, et al.
Published: (2012)

Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).
by: Daniele Campa, et al.
Published: (2011-02-01)

Serum vitamin d and risk of prostate cancer in a case-control analysis nested within the european prospective investigation into cancer and nutrition (EPIC)
by: Travis, R, et al.
Published: (2009)

Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
by: Rinaldi, S, et al.
Published: (2007)

Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
by: Perez-Cornago, A, et al.
Published: (2017)

A prospective analysis of the association between dietary fiber intake and prostate cancer risk in EPIC.
by: Suzuki, R, et al.
Published: (2009)

Risk factors for cancers of unknown primary site: Results from the prospective EPIC cohort
by: Kaaks, R, et al.
Published: (2014)

Risk factors for cancers of unknown primary site: Results from the prospective EPIC cohort.
by: Kaaks, R, et al.
Published: (2014)

Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).
by: Travis, R, et al.
Published: (2009)

Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC).
by: Franceschi, S, et al.
Published: (2011)

Dietary Intake of Acrylamide and Epithelial Ovarian Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.
by: Obón-Santacana, M, et al.
Published: (2015)

Physical activity of subjects aged 50-64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC).
by: Haftenberger, M, et al.
Published: (2002)

Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
by: Allen, N, et al.
Published: (2008)

N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort.
by: Pesch, B, et al.
Published: (2013)

Mediterranean dietary pattern and cancer risk in the EPIC cohort
by: Couto, E, et al.
Published: (2011)

Mediterranean dietary pattern and cancer risk in the EPIC cohort.
by: Couto, E, et al.
Published: (2011)

Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort
by: Fortner, RT, et al.
Published: (2017)

Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study
by: Perez-Cornago, A, et al.
Published: (2017)

Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC).
by: Lahmann, P, et al.
Published: (2005)

Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort
by: Fortner, RT, et al.
Published: (2017)

Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
by: Romieu, I, et al.
Published: (2012)

Consumption of dairy products and colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
by: Murphy, N, et al.
Published: (2013)

Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutrition.
by: Travis, R, et al.
Published: (2013)

Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutrition
by: Travis, R, et al.
Published: (2013)

Weight change in middle adulthood and breast cancer risk in the EPIC-PANACEA study.
by: Emaus, M, et al.
Published: (2014)

Weight change in middle adulthood and breast cancer risk in the EPIC-PANACEA study
by: Emaus, M, et al.
Published: (2014)

Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).
by: Allen, N, et al.
Published: (2008)

Breast cancer risk in relation to abortion: Results from the EPIC study.
by: Reeves, G, et al.
Published: (2006)

Breast cancer risk in relation to abortion: Results from the EPIC study
by: Reeves, G, et al.
Published: (2006)

Red meat, dietary nitrosamines, and heme iron and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
by: Jakszyn, P, et al.
Published: (2011)

The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort.
by: Grote, V, et al.
Published: (2012)